Citius Oncology (CTOR) Current Assets (2021 - 2026)
Citius Oncology (CTOR) reported Current Assets of $42.71 million for fiscal Q3 2026 (quarter ended Jun 30, 2026), up 133.3% from $18.31 million a year earlier and up 45.1% from the prior quarter.
Citius Oncology (CTOR) Current Assets (2021 - 2026) Analysis & Trends
At the end of FY2025 (ended Sep 30, 2025), Citius Oncology posted Current Assets of $27.54 million, up 151.1% from FY2024.
- Current Assets has a four-year compound annual growth rate of 284.2% (FY2021 to FY2025).
- By fiscal year, Current Assets came in at $10.97 million in FY2024, $58,200 in FY2023 (-84.6%), $377,344 in FY2022 (+198.5%) and $126,422 in FY2021.
- The fiscal Q3 2026 figure ranks as the highest quarterly Current Assets in data going back to fiscal Q4 2021.
- Year over year, Current Assets has now increased in each of the last four quarters, with growth averaging 116.2% over the last four quarters.
- The high point for year-over-year Current Assets in five years was fiscal Q4 2022 (growth of 198.5%); the low point was fiscal Q2 2024 (a decline of 91.1%).
- Per Business Quant data, the three fiscal quarters before Q3 2026 came in at $29.42 million (Q2 2026), $37.15 million (Q1 2026) and $27.54 million (Q4 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,348.13 Bn | 1,321.74 Bn | 20.46 Bn | 65.26 Bn |
| 2 | Johnson & Johnson | 675.90 Bn | 595.76 Bn | 17.30 Bn | 56.35 Bn |
| 3 | AbbVie | 519.45 Bn | 487.50 Bn | 13.12 Bn | 37.48 Bn |
| 4 | Merck | 364.95 Bn | 327.95 Bn | 13.19 Bn | 38.94 Bn |
| 5 | Novartis Ag | 311.58 Bn | 285.16 Bn | - | - |
| 6 | Astrazeneca | 289.34 Bn | 262.94 Bn | 13.26 Bn | 31.45 Bn |
| 7 | Amgen | 251.64 Bn | 203.30 Bn | 7.58 Bn | 34.36 Bn |
| 8 | Gilead Sciences | 212.05 Bn | 187.07 Bn | 6.73 Bn | 16.55 Bn |
| 9 | Pfizer | 167.35 Bn | 115.00 Bn | 12.56 Bn | 45.01 Bn |
| 10 | Citius Oncology | 60.42 Mn | 30.00 Mn | 1.00 Mn | 42.71 Mn |
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 42.71 Mn |
| Mar 31, 2026 | 29.42 Mn |
| Dec 31, 2025 | 37.15 Mn |
| Sep 30, 2025 | 27.54 Mn |
| Jun 30, 2025 | 18.31 Mn |
| Mar 31, 2025 | 18.04 Mn |
| Dec 31, 2024 | 17.08 Mn |
| Sep 30, 2024 | 10.97 Mn |
| Jun 30, 2024 | 40,988.00 |
| Mar 31, 2024 | 94,394.00 |
| Dec 31, 2023 | 58,200.00 |
| Sep 30, 2023 | 7.73 Mn |
| Jun 30, 2023 | 461,907.00 |
| Mar 31, 2023 | 245,366.00 |
| Dec 31, 2022 | 377,344.00 |
| Dec 31, 2021 | 126,422.00 |
Citius Oncology Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=current-assets&ticker=CTOR&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "current-assets", "ticker": "CTOR", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=current-assets&ticker=CTOR&period=max&api_key=YOUR_API_KEY");
const data = await res.json();